Evidence mapPaperPMID 36750874Full record

ReviewBiology of sex differences2023

Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases.

Jose Antonio Santos-Marcos, Marina Mora-Ortiz, Manuel Tena-Sempere, Jose Lopez-Miranda, Antonio Camargo

Open access · goldAbstract readReview
In one paragraph

Review in Biology of sex differences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
22.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Sweat components as a promising monitoring tool for systemic diseases.The journal of physiological sciences : JPS · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jose Antonio Santos-MarcosLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004, Córdoba, Spain.
Marina Mora-OrtizLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004, Córdoba, Spain.
Manuel Tena-SempereMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Av. Menendez Pidal, s/n., 14004, Córdoba, Spain.
Jose Lopez-MirandaLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004, Córdoba, Spain.
Antonio CamargoLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004, Córdoba, Spain. antonio.camargo@imibic.org.ORCID 0000-0002-0415-4184
Instituto de Salud Carlos III · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ES

Funding

Consejería de Salud y Familias, Junta de Andalucía PI-0055-2021Instituto de Salud Carlos III CP14/00114Instituto de Salud Carlos III CPII19/00007Instituto de Salud Carlos III PI19/00299Instituto de Salud Carlos III PI22/00925
6 · The paper itself

Abstract

Metabolic diseases, such as obesity, metabolic syndrome (MetS) and type 2 diabetes (T2D), are now a widespread pandemic in the developed world. These pathologies show sex differences in their development and prevalence, and sex steroids, mainly estrogen and testosterone, are thought to play a prominent role in this sexual dimorphism. The influence of sex hormones on these pathologies is not only reflected in differences between men and women, but also between women themselves, depending on the hormonal changes associated with the menopause. The observed sex differences in gut microbiota composition have led to multiple studies highlighting the interaction between steroid hormones and the gut microbiota and its influence on metabolic diseases, ultimately pointing to a new therapy for these diseases based on the manipulation of the gut microbiota. This review aims to shed light on the role of sexual hormones in sex differences in the development and prevalence of metabolic diseases, focusing on obesity, MetS and T2D. We focus also the interaction between sex hormones and the gut microbiota, and in particular the role of microbiota in aspects such as gut barrier integrity, inflammatory status, and the gut-brain axis, given the relevance of these factors in the development of metabolic diseases.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeMetabolic SyndromeFemaleGonadal Steroid HormonesHumansMaleObesitySex CharacteristicsGonadal Steroid HormonesGut microbiotaMetabolic syndromeObesitySex differencesSex steroidsType 2 diabetes

Identifiers

PMID36750874
PMCPMC9903633
OpenAlexW4319350120

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.